This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision Next revisionBoth sides next revision |
content:acetazolamide [2020/02/02 11:45] – icna | content:acetazolamide [2022/04/30 12:46] – administrator@icnapedia.org |
---|
====== Acetazolamide ====== | ====== Acetazolamide ====== |
| {{page>template:citecheck}} |
===== Authorised indications ===== | ===== Authorised indications ===== |
| |
| |
Acetazolamide has limited use as an adjunctive therapy for a variety of seizures, but mainly absences | Acetazolamide has limited use as an adjunctive therapy for a variety of seizures, but mainly absences |
[(:cite:pmid11393330><html>Panayiotopoulos CP (2001) <a href="https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11393330">Treatment of typical absence seizures and related epileptic syndromes.</a> <i>Paediatr Drugs</i> 3 (5):379-403. DOI: <a href="http://dx.doi.org/10.2165/00128072-200103050-00006">10.2165/00128072-200103050-00006</a> PMID: <a href="https://pubmed.gov/11393330">11393330</a></html>)]. However, it also controls myoclonic jerks, generalised tonic–clonic seizures (GTCSs) and focal seizures. It is particularly used for intermittent administration in catamenial epilepsy (5 days before the expected onset of menses and continued until termination of bleeding)[(:cite:pmid11422329><html>Lim LL, Foldvary N, Mascha E, Lee J (2001) <a href="https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11422329">Acetazolamide in women with catamenial epilepsy.</a> <i>Epilepsia</i> 42 (6):746-9. DOI: <a href="http://dx.doi.org/10.1046/j.1528-1157.2001.33600.x">10.1046/j.1528-1157.2001.33600.x</a> PMID: <a href="https://pubmed.gov/11422329">11422329</a></html>)];it is not recommended if there is a likelihood of pregnancy. | [(:cite:pmid11393330>{{pmid>long:11393330}})]. However, it also controls myoclonic jerks, generalised tonic–clonic seizures (GTCSs) and focal seizures. It is particularly used for intermittent administration in catamenial epilepsy (5 days before the expected onset of menses and continued until termination of bleeding)[(:cite:pmid11422329>{{pmid>long:11422329}})];it is not recommended if there is a likelihood of pregnancy. |
| |
===== Dosage and titration ===== | ===== Dosage and titration ===== |